The genetic and biochemical basis of trimethylaminuria in an Irish cohort. Issue 1 (25th March 2019)

• Record Type: Journal Article
• Authors: Doyle, Samantha; O'Byrne, James J.; Nesbitt, Mandy; Murphy, Daniel N.; Abidin, Zaza; Byrne, Niall; Pastores, Gregory; Kirk, Richard; Treacy, Eileen P.
• Is Part Of: JIMD reports. Volume 47:Issue 1(2019)
• Page Start: 35
• Page End: 40
• Publication Date: 2019-03-25
• Subjects: fish odor syndrome -- FMO3 gene -- genetic polymorphism -- genotype -- trimethylamine -- trimethylamine N‐oxide; Metabolism, Inborn errors of -- Periodicals; Metabolism -- Disorders -- Periodicals; 616.39042
• DOI: 10.1002/jmd2.12028
• Languages: English
• ISSNs: 2192-8304

Abstract

Abstract: Background: Inherited trimethylaminuria (TMAU), a rare genetic disorder of hepatic metabolism of trimethylamine (TMA) causing excessive accumulation of malodorous trimethylamine (TMA), is a socially distressing disorder. Diagnosis is made by biochemical analysis of urine, with the calculation of flavin monooxygenase trimethylamine conversion capacity. Genetic testing, sequencing the entire coding region of the FMO3 gene has been recommended for affected individuals who convert less than 90% of the total TMA load to TMAO. Methods: Genetic analysis was undertaken for 13 Irish patients with TMAU of varying phenotypic severity (three severe, six moderate, and four mild). Results: A genetic diagnosis was made for seven patients, including for five of the nine moderate to severely affected cases. We noted the c.913G>T;p.(Glu305*) and c.458C>T;p.(Pro153Leu) mutations in this Irish population with severe TMAU which is consistent with our earlier findings in Australian and North American families of Irish and British descent. Three individuals were noted to be homozygous for the common variant haplotype c.472G>A;923A>G;p.(Glu158Lys);(Glu308Gly). We also identified three novel variants in this population, which are likely to be pathogenic: c.682G>A;p(Gly228Ser), c.694G>T:p(Asp232Tyr), and c.989G>A;p.(Gly330Glu). Conclusion: Urinary biochemical analysis probably remains the first line diagnostic approach to classify the various types of TMAU. FMO3 gene analysis is likely only to be informative for certain presentations of TMAU.